Aldeyra Therapeutics Inc - fluxo de caixa (NASDAQ:ALDX) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -37.49 M-42.56 M-56.64 M-30.33 M-43.21 M-33.35 M -33.35 M Cash from investing activities 29.02 M-7 806-29.95 M30 M-44.92 M47.74 M 47.74 M Cash from financing activities 41.9 M194.5 M1.22 M-1.27 M-171.42 K1.12 M 1.12 M Free cash flow -37.49 M-42.56 M-56.65 M-30.33 M-43.21 M-33.35 M -33.35 M

Notícias

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

Aldeyra Therapeutics quita préstamo de US$ 15 milhões com Hercules e encerra linha de crédito

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

H.C. Wainwright rebaixa classificação da Aldeyra após revés com FDA

BTIG mantém recomendação de compra para Aldeyra Therapeutics após revés com FDA

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

E.U.A. - Ações fecharam o pregão em alta e o Índice Dow Jones Industrial Average avançou 0,10%

RBC reitera classificação de ações da Bausch & Lomb após atraso de rival

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?